evoxx technologies

evoxx technologies GmbH is an industrial biotechnology company specializing in the development and production of industrial enzymes and tailor-made biocatalysts. Originally founded as evocatal GmbH in 2006 by Thorsten Eggert, the company became evoxx technologies in 2016 after merging with carbohydrate specialist aevotis GmbH. It operates as a spin-off from the Institute of Molecular Enzyme Technology at Heinrich-Heine University in Dusseldorf. In August 2017, evoxx was acquired by Advanced Enzyme Technologies Ltd. (AETL), a global enzyme manufacturer listed on the Mumbai stock exchange, for €7.65 million. This acquisition positioned evoxx as AETL's European headquarters and expanded the group's R&D capabilities through evoxx's expertise in directed evolution and metagenome technologies.

The company serves a wide range of industries, including human nutrition, animal nutrition, food processing, pharmaceuticals, textiles, and biocatalysis. Its business model focuses on providing a comprehensive portfolio of over 400 proprietary enzymatic solutions and developing unique enzymes for differentiated consumer products. evoxx assists clients from the initial concept stage through to production and deregulation. The company's products include novel carbohydrate ingredients created through enzymatic bioconversion, which are used in the food and health sectors to provide consumer health benefits. With laboratories equipped to S1 and S2 standards, evoxx develops processes up to a commercial scale for its global customer base spanning 45 countries.

Keywords: enzyme development, biocatalysis, industrial enzymes, biotechnology, probiotics, enzymatic bioconversion, food ingredients, animal nutrition, human nutrition, pharmaceutical enzymes, directed evolution, metagenomics, tailor-made enzymes, bio-catalytic processes, carbohydrate ingredients, enzyme manufacturing, food processing solutions